Pharmacists' experiences on adverse drug reaction: 10 years later

被引:2
|
作者
Karuppannan, Mahmathi [1 ]
Rizal, Nur Azzrin Nisha Mohamad [2 ]
Wong, Kok-Thong [3 ]
Ali, Salmiah Mohd [4 ]
Ting, Kang-Nee [3 ]
Boardman, Helen [5 ]
机构
[1] Univ Teknol MARA UiTM Cawangan Selangor, Fac Pharm, Dept Pharm Practice, Puncak Alam Campus, Shah Alam, Malaysia
[2] Hosp Sultanah Nora Ismail, Batu Pahat, Malaysia
[3] Univ Nottingham Malaysia, Sch Pharm, Semenyih, Malaysia
[4] Asian Metropolitan Univ, Kuala Lumpur, Malaysia
[5] Univ Nottingham, Sch Pharm, Div Pharm Practice & Policy, Nottingham, England
关键词
adverse drug reaction; pharmacists; community pharmacists; reporting ADRs; survey; COMMUNITY PHARMACISTS; KNOWLEDGE; PHARMACOVIGILANCE; PREVALENCE; ATTITUDES; ADMISSION; BARRIERS;
D O I
10.3389/fphar.2022.932942
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adverse drug reaction (ADR) is one of the leading public health concerns associated with high mortality rate. Healthcare professionals, particularly pharmacists, have a significant role in monitoring and preventing ADRs. This study was conducted on Malaysian Pharmaceutical Society (MPS) pharmacists who worked at the hospitals, health clinics, and community pharmacies to determine if pharmacists' experiences on ADRs are still the same 10 years later. In 2010, a postal survey and in 2020, an online survey were conducted among these pharmacists. A total of 472 pharmacists and 208 participated in 2010 and 2020, respectively. About 82% and 90% of hospital/health clinic pharmacists (HCPs) observed an ADR over the last 6 months in 2010 and 2020, while 60% and 100% community pharmacists in 2010 and 2020 observed an ADR, respectively. Perindopril was the top drug (HCPs: p = 0.657; CPs: p = 0.98), and rash was the top ADR reported by the pharmacists in both years (HCPs: p < 0.001; CPs: p = 0.679). The most common actions taken by HCPs in 2010 were to report the ADR (p = 0.343), while in 2020, most HCPs explained to patients regarding the reaction (p = 0.061), which was also the same in the CP group in 2020 (p = 0.958). The top factor encouraging ADR reporting in both years and both pharmacist groups was the high degree of severity of the reaction (HCPs: p < 0.001; CPs: p = 0.769). While the top factors discouraging ADR reporting were a lack of information from the affected patients (HCPs: p = 0.2; CPs: p = 0.656), reaction is widely known (HCPs: p = 0.001; CPs: p = 0.144) and uncertainty of the causal relationship (HCPs: p = 0.169; CPs: p = 0.609). Majority of the pharmacists agreed that severe reactions should be reported (HCPs: p = 0.158; CPs: p = 0.501) and the main aim for reporting is to measure the incidence of ADRs (HCPs: p = 0.148; CPs: p = 0.762). Despite being able to identify ADRs during the daily practice, many pharmacists especially community pharmacists are not reporting them. There is a misconception on the purpose of reporting ADRs. An interventional program and ADR reporting training would be a useful step in improving ADR reporting practice.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] PHARMACISTS ATTITUDES TOWARD ADVERSE DRUG REACTION REPORTING IN HONG-KONG
    LEE, KKC
    CHAN, TYK
    RAYMOND, K
    CRITCHLEY, JAJH
    ANNALS OF PHARMACOTHERAPY, 1994, 28 (12) : 1400 - 1403
  • [22] 10 Years later
    Tschiersky-Schoeneburg, Helmut
    JOURNAL FUR VERBRAUCHERSCHUTZ UND LEBENSMITTELSICHERHEIT-JOURNAL OF CONSUMER PROTECTION AND FOOD SAFETY, 2012, 7 (04): : 269 - 271
  • [23] 10 years later!
    Serin, D.
    Culine, S.
    Gligorov, J.
    Krakowski, I.
    Marti, P.
    Schneider, M.
    Spielmann, M.
    ONCOLOGIE, 2010, 12 (01) : 1 - 2
  • [24] 10 years later ...
    Valiquette, Louis
    Laupland, Kevin B.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2013, 24 (04): : 175 - 176
  • [25] THE DRUG SCENARIO OF THE PAST 10 YEARS - EXPERIENCES AND QUESTIONS
    LADEWIG, D
    DRUG AND ALCOHOL DEPENDENCE, 1983, 11 (01) : 43 - 47
  • [26] 10 YEARS LATER
    KOTSHER, BJ
    ELASTOMERICS, 1981, 113 (03): : 8 - 8
  • [27] Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia (vol 22, pg 411, 2014)
    Mahmoud, Mansour Adam
    Alsowaida, Yazed
    Alshammari, Thamir
    Khan, Tahir Mehmood
    Alrasheedy, Alian
    Hasssali, Mohamad Azmi
    Aljadhey, Hisham
    SAUDI PHARMACEUTICAL JOURNAL, 2018, 26 (01) : 144 - 144
  • [28] Community Pharmacists' Knowledge, Behaviors and Experiences about Adverse Drug Reactions Reporting in Saudi Arabia
    Mahmoud, Mansour A.
    Alswaida, Yazeed
    Alshammari, Thamir
    Hassali, Mohamed Azmi
    Aljadhey, Hisham
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 434 - 435
  • [29] BARRIERS AND FACILITATORS OF REPORTING ADVERSE DRUG REACTION AMONG HOSPITAL PHARMACISTS IN NIGERIA AND USA
    Temedie-Asogwa, T.
    Khalid, J.
    Zakeri, M.
    Sansgiry, S. S.
    VALUE IN HEALTH, 2022, 25 (07) : S484 - S484
  • [30] Facilitators and barriers towards adverse drug reaction reporting: perspective of Malaysian hospital pharmacists
    Hadi, Muhammad Abdul
    Helwani, Ruwaida
    Long, Chiau Ming
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2013, 4 (03) : 155 - 158